Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Ceres Prices IPO Of 5.0 Mln Shares At $13/Shr - Quick Facts

RELATED NEWS
Trade CERE now with 

Energy crop company Ceres Inc. (CERE: Quote) said it has priced its initial public offering of 5.0 million shares at $13.00 per share. The common stock may begin trading on the NASDAQ Global Market on February 22, 2012 under the ticker symbol "CERE." The underwriters have been granted a 30-day option to buy up to an additional 750,000 common shares from Ceres.

The offering may close on February 27, 2012, with all shares being offered by Ceres. Goldman, Sachs & Co. and Barclays Capital acted as joint book-running managers for the offering and Piper Jaffray, Raymond James and Simmons & Company International acted as co-managers

Click here to receive FREE breaking news email alerts for CERES, INC. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Amazon.com, Inc. said Thursday that its second quarter loss widened from last year, as operating expenses outpaced revenue growth amid heavy spending on new technology and contents. The company's quarterly loss per share was also wider than what analysts expected, but is quarterly sales came in line with analysts' forecast. The company also forecast an operating loss for the current quarter. After failing to sustain an initial upward move, stocks showed a lack of direction throughout much of the trading day on Thursday. The major averages eventually closed nearly unchanged, turning in a mixed performance for the second straight day. New home sales in the U.S. showed a notable decrease in the month of June, according to a report released by the Commerce Department on Thursday, with the steep drop offsetting the jump seen in the previous month.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.